Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 1/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | SCN1A | P35498 | 1/20 | 0.45 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.45 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.45 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10299637 | 0.94 | LTA4H (0.53) | NQO1ADRA2AALDH1A1TSHRCYP3A4 | |
| SCHEMBL7526584 | 0.88 | ALDH1A1 (0.49) | NQO1ADRA2AALDH1A1TSHRCYP3A4 | |
| SCHEMBL414168 | 0.85 | CYP1A2 (0.50) | TSHRCYP3A4CYP1A2GAARAB9A | |
| SCHEMBL991987 | 0.85 | CYP2C9 (0.50) | ALDH1A1TSHRCYP3A4CYP1A2KMT2A | |
| SCHEMBL8568163 | 0.83 | CYP3A4 (0.54) | NQO1ADRA2AALDH1A1TSHRCYP3A4 | |
| SCHEMBL10341829 | 0.83 | CYP3A4 (0.54) | ALDH1A1TSHRCYP3A4CYP1A2TDP1 | |
| SCHEMBL631317 | 0.82 | NQO1 (0.58) | NQO1ADRA2AALDH1A1TSHRCYP3A4 | |
| SCHEMBL1493053 | 0.82 | CYP3A4 (0.52) | ALDH1A1TSHRCYP3A4CYP1A2TDP1 | |
| SCHEMBL10341873 | 0.82 | CYP3A4 (0.52) | TSHRCYP3A4CYP1A2TDP1GAA | |
| Ether SCHEMBL2581487 | 0.81 | CYP3A4 (0.47) | NQO1ADRA2AALDH1A1TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 419 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103724293-B | A kind of preparation method of the urea derivative containing 1,2,3-thiadiazoles | 浙江工业大学 | 2016-08-17 | — | — | CN | claimed |
| CN-103613564-B | Preparation method of amido urea derivative containing 1, 2, 3-thiadiazole | UNIV ZHEJIANG TECHNOLOGY | 2015-05-06 | — | — | CN | claimed |
| US-7674842-B2 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION (US) | 2010-03-09 | — | — | US | claimed |
| US-7541406-B2 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION (US) | 2009-06-02 | — | — | US | claimed |
| US-20070120909-A1 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION | 2007-05-31 | — | — | US | claimed |
| US-20070123642-A1 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| EP-0034711-A2 | Process for preparing aromatic isocyanates with aromatically bound sulfochloride groups | BAYER AG (DE) | 1981-09-02 | — | — | EP | claimed |
| WO-2026104221-A1 | PROCESS FOR PREPARING OF ORGANIC CARBAMOYL AZIDES | All4Labels Group GmbH (DE) | 2026-05-21 | — | — | WO | disclosed |
| EP-4190869-B1 | A PRINTING METHOD FOR TIME TEMPERATURE INDICATORS | AGFA GEVAERT NV (BE) | 2026-02-25 | — | — | EP | disclosed |
| US-20250035600-A1 | A Printing Method for Time Temperature Indicators | AGFA-GEVAERT NV (BE) | 2025-01-30 | — | — | US | disclosed |
| US-20240417377-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR SELECTIVELY INHIBITING ß-GLUCURONIDASES AND ALLEVIATING SIDE EFFECTS ASSOCIATED WITH DRUG TREATMENT INDUCED DIARRHEA | SYMBERIX, INC. | 2024-12-19 | — | — | US | disclosed |
| WO-2024242056-A1 | CYCLIC PEPTIDE COMPOUND AND ANTIBACTERIAL AGENT COMPRISING SAME | 学校法人近畿大学 | 2024-11-28 | — | — | WO | disclosed |
| CN-118414391-A | Printing method of time temperature indicator | 爱克发-格法特公司 | 2024-07-30 | — | — | CN | disclosed |
| US-3972894-A | Synthesis of oxindoles from anilines and β-thio carboxylic esters or amides | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1976-08-03 | — | — | US | disclosed |
| US-3963763-A | Anthraquinone dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-15 | — | — | US | disclosed |
| US-3961061-A | INSECTICIDES, FUNGICIDES, BACTERICIDES, MITICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-01 | — | — | US | disclosed |
| US-3936484-A | Production of isocyanates from substituted ureas | ATLANTIC RICHFIELD COMPANY (US) | 1976-02-03 | — | — | US | disclosed |
| US-3935277-A | OIL AND WATER REPELLENT INTERMEDIATES | CIBA-GEIGY CORPORATION (US) | 1976-01-27 | — | — | US | disclosed |
| US-3931171-A | FROM A 1,3-DIOXINONE-(4) AND AN ISOCYANATE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240417377-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR SELECTIVELY INHIBITING ß-GLUCURONIDASES AND ALLEVIATING SIDE EFFECTS ASSOCIATED WITH DRUG TREATMENT INDUCED DIARRHEA | GUSB, SI, ENGASE | NQO1 824/4885ADRA2A 894/4885ALDH1A1 369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.